ALFA Finder| Value | ₹1.21 Cr |
|---|
BSE filing, BSE: 545020. Summary written from the filing by ALFA Finder's alert engine.
Vectras Enprocon Ltd: key numbers
- Share price
- ₹106.70
- Market cap
- ₹203.3 Cr
- Revenue (annual)
- ₹119.8 Cr
- Net profit (annual)
- ₹15.43 Cr
- P/E (TTM)
- 13.2×Sector 33.5×
- Promoter holding
- 73.49%
- FII holding
- 2.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vectras Enprocon Ltd
All →Vectras Enprocon Other Announcement
Director Ravi P Patel bought 12,000 Vectras Enprocon shares for Rs. 0.13 Crore on BSE. No promoter involvement in this routine market purchase.
- Value
- ₹0.13 Cr
Vectras Enprocon Other Announcement
Vectras Enprocon disclosed CS Arpit Thakkar as Compliance Officer, effective 23 September 2025. The intimation only lists an existing KMP and makes no new appointment.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr